RDTCF.US Rapid Dose Therapeutics Corp

Healthcare Biotechnology USA Stocks
0.0572 USD
Close of Nov 18, 2026
0.0132 0.1500
Market cap
USD 7.88M
P/E
-
P/B
29.59x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.

Is RDTCF.US undervalued?

Graham number

The Graham number of Rapid Dose Therapeutics Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rapid Dose Therapeutics Corp fundamental analysis

No fundamental analysis for Rapid Dose Therapeutics Corp yet.

Rapid Dose Therapeutics Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rapid Dose Therapeutics Corp

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. It also provides over-the-counter products consisting of QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12; and QuickStrip Sleep to del…

Full company profile